HEALTH CATALYST INC - NOTE 2.500% 4/1

CUSIP: 42225TAB3

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Debt / NOTE 2.500% 4/1
Market price (% of par)
99.63%
Total 13F principal
$208,026,606
Principal change
-$2,625,975
Total reported market value
$229,496,329
Number of holders
15
Value change
-$2,552,048
Number of buys
2
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 42225TAB3?
CUSIP 42225TAB3 identifies 42225TAB3 - HEALTH CATALYST INC - NOTE 2.500% 4/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HEALTH CATALYST INC - NOTE 2.500% 4/1 as of Q1 2025

As of 31 Mar 2025, HEALTH CATALYST INC - NOTE 2.500% 4/1 was held by 15 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $208,026,606 in principal (par value) of the bond. The largest 10 bondholders included TENOR CAPITAL MANAGEMENT Co., L.P., Linden Advisors LP, LAZARD ASSET MANAGEMENT LLC, Opti Capital Management, LP, PIPER SANDLER & CO., Kohlberg Kravis Roberts & Co. L.P., WELLINGTON MANAGEMENT GROUP LLP, OAKTREE CAPITAL MANAGEMENT LP, Russell Investments Group, Ltd., and Context Capital Management, LLC. This page lists 15 institutional bondholders reporting positions for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.